Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence

被引:9
|
作者
Rajesh, V [1 ]
Augustine, Jolsana [1 ]
Divya, R. [1 ]
Cleetus, Melcy [1 ]
机构
[1] Rajagiri Hosp, Dept Pulm Med, Kochi, Kerala, India
关键词
FIXED-DOSE COMBINATION; ADULT PATIENTS; DRY-POWDER; RELATIVE BIOAVAILABILITY; OPEN-LABEL; PROPIONATE; ONSET; BUDESONIDE/FORMOTEROL; SALBUTAMOL; ADOLESCENT;
D O I
10.1155/2020/8631316
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Asthma is the commonest chronic disease affecting airways in humans and has an increasing global disease burden. Inhaled corticosteroids (ICS) are the first-line therapeutic option for asthma, and addition of a long-acting beta 2-agonist (LABA) has been shown to improve asthma control. A combination of the two agents in a single inhaler is beneficial with regard to ease of administration and patient compliance. Various ICS-LABA formulations are available across various countries in the world, one among them being formoterol-fluticasone. Both formoterol and fluticasone have pharmacologic peculiarities which places the combination in a uniquely advantageous position when it comes to asthma therapy. The present review focuses on some of the, hitherto, less explored aspects of this combination inhaler such as real-world efficacy, impact on budget allocation, results of switch-over therapy, and potential to improve adherence to asthma treatment. It also provides practical recommendations on positioning it in real-world asthma management.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Comparing the safety and efficacy of fluticasone/formoterol combination therapy in a single inhaler at low and medium doses, with fluticasone and formoterol concurrently or alone, in asthma patients
    Hochhaus, G.
    Kaiser, K.
    ALLERGY, 2011, 66 : 585 - 585
  • [2] REAL-WORLD ADHERENCE TO SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL VERSUS MULTIPLE-INHALER TRIPLE THERAPY AMONG ASTHMA PATIENTS IN THE US
    Averell, C.
    Germain, G.
    Laliberte, F.
    MacKnight, S.
    Jung, Y.
    Duh, M. S.
    Abbott, C.
    VALUE IN HEALTH, 2021, 24 : S13 - S13
  • [3] Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Francois
    Mahendran, Malena
    Duh, Mei Sheng
    Dirocco, Kristi
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    Balkissoon, Ronald
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1309 - 1322
  • [4] Utility and efficacy of fluticasone propionate and salmeterol inhaled from a single inhaler for persistent asthma
    Mathison, DA
    Koziol, JA
    JOURNAL OF ASTHMA, 2005, 42 (10) : 829 - 831
  • [5] Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan
    Oga, Toru
    Mita, Chifuku
    Ito, Risako
    Requena, Gema
    Rothnie, Kieran J.
    Noorduyn, Stephen G.
    Yuanita, Liza
    Yarita, Masao
    RESPIRATORY INVESTIGATION, 2024, 62 (04) : 685 - 694
  • [6] Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?
    Sovani, Milind P.
    Whale, Christopher I.
    Oborne, Janet
    Cooper, Sue
    Mortimer, Kevin
    Ekstrom, Tommy
    Tattersfield, Anne E.
    Harrison, Timothy W.
    BRITISH JOURNAL OF GENERAL PRACTICE, 2008, 58 (546): : 37 - 43
  • [7] Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India
    Ghoshal, Aloke
    Waghray, Pradyut
    Dsouza, George
    Saluja, Mahip
    Agarwal, Mayank
    Goyal, Ashish
    Limaye, Sneha
    Balki, Akash
    Bhatnagar, Sudhir
    Jain, Manish
    Tikkiwal, Sharad
    Vaidya, Abhijit
    Lopez, Meena
    Hegde, Rashmi
    Gogtay, Jaideep
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 60
  • [8] Clinical effectiveness of adjustable dosing single inhaler budesonide/formoterol for asthma and budget impact analysis
    Kaczor, M.
    Becla, L.
    Wojcik, R.
    Dardzinski, W.
    Walczak, J.
    Nogas, G.
    VALUE IN HEALTH, 2006, 9 (06) : A332 - A332
  • [9] Real-world efficacy of "fixed triple" single-inhaler combinations in COPD and asthma patients
    Mochizuki, Taichi
    Arai, Hiroyuki
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Umeda, Akira
    To, Yasuo
    Tsushima, Kenji
    RESPIROLOGY, 2023, 28 : 311 - 312
  • [10] A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler
    Latorre, M.
    Paggiaro, P.
    Canonica, W.
    Foschino, M. P.
    Papi, A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 34 : 31 - 36